An MIA was undertaken to identify complexities contributing to medication errors during care at end of life. The 3 themes identified were (1) hesitancy to treat opioid toxicity with naloxone, (2) errors in medication use processes such as transcription errors and administration errors, and (3) gaps in coordination of care.
- Telephone orders and verbal orders
- Transitions of care
- Consumer “Good Catches”
- Health Canada’s Policy Statement on the Naming of Biologic Drugs